ClinicalTrials.gg
RecruitingNCT05884073C4C+Updated Jun 1, 2026

Exercise for Oncology Care Professionals

An interventional study of Circuit-based Resistance Training and Nature-based Walking in Burnout, Caregiver and Compassion Fatigue, sponsored by Melanie Keats. Recruiting at 2 sites in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-01.

Sponsored by Melanie Keats · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this preference-based pilot study will be to assess the feasibility and acceptability, and impact of a 12-week exercise intervention on oncology care provider burnout. Participants self-select to participate into one of two exercise groups. Group assignment will be based on participant preference.

Group 1: Supervised circuit-based resistance exercise

Group 2: Nature-based walking

02

Conditions studied

  • Burnout, Caregiver
  • Compassion Fatigue

Keywords

  • oncology health professionals
  • burnout
  • exercise
  • physical activity
  • nature-based walking
03

In context

Caregiver Burden

500 studies on the registry are indexed under Caregiver Burden; 164 are open to participants now.

This study's planned enrollment of 70 is close to the median of 71 across 402 interventional studies indexed under Caregiver Burden.

Browse Caregiver Burden studies →

Lead sponsor

Melanie Keats is the lead sponsor of 2 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years of age or older;
  • Able to speak/write in English;
  • Must be providing formal care to cancer patients in a clinical setting within the Halifax Municipality;
  • Actively practicing within the Nova Scotia Cancer Care Program; and
  • Able and willing to engage in low-to-moderate intensity physical activity.

Exclusion criteria

Exclusion Criteria:

  • Exceeding Canadian physical activity guidelines of 150-minutes of moderate-to-vigorous physical activity per week; and
  • Any health condition that would preclude safe participation in a new exercise program.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Circuit-based resistance exercise

    12-week, supervised circuit-based resistance training program (2-3 times/week).

    Behavioral: Circuit-based Resistance Training

  • Active comparator
    Nature Walking

    12-weeks self-paced walking in nature (2-3 times/week).

    Behavioral: Nature-based Walking

Interventions

  • BehavioralCircuit-based Resistance Training

    Participants will engage in a 12-week circuit-based resistance training program 2-3 times/week. Each supervised session will last about 30 minutes and will consist of 5 resistance exercises. Each exercise will be completed for 1 minute for a total of 5 minutes followed by a 1-minute rest. The circuit will then repeated 3 additional times (total of 4 circuits). All resistance sessions will be supervised by a certified fitness professionals.

  • BehavioralNature-based Walking

    Participants will be asked to engage in 30 minutes of self-paced walking in nature 2-3 days/week. Participants will be provided with a list of resources that direct them to walkable nature/green spaces close to their home or workplace.

06

What researchers measure

Primary outcomes

  1. Feasibility - Participant Fidelity (Intervention Adherence)

    Participant adherence to prescribed exercise intervention

    Time frame: Through study completion (about 2 years)

  2. Feasibility - Safety

    Adverse and serious adverse events

    Time frame: Through study completion (about 2 years)

  3. Feasibility - Retention/Attrition

    Percentage of participants who complete the 12-week intervention

    Time frame: Through study completion (about 2 years)

  4. Feasibility - Attendance

    Attendance is calculated as the percentage of exercise sessions completed by the total number of available exercise sessions over the 12-week intervention.

    Time frame: Through study completion (about 2 years)

  5. Feasibility - Recruitment

    Participant accrual as defined as the number of eligible participants who express an interest in participation divided by the number of participants who consent to participate.

    Time frame: Through study completion (about 2 years)

  6. Feasibility - Participant Experience

    Interviews with a diverse group of participants will be used to assess factors influencing participant selection of intervention type/setting, adherence to and satisfaction with the selected intervention.

    Time frame: Through study completion (about 2 years)

Secondary outcomes

  1. Maslach Burnout Inventory (MBI) for Medical Personnel (MP)

    The MBI-MP is used to assess burnout in medical professionals. The 22-item, 7-point Likert scale (0 = never to 6 = everyday) assesses burnout across three dimensions: emotional exhaustion (9 items), personal accomplishment (8 items), and depersonalization (5-items).

    Time frame: Baseline, mid-program (6-weeks), and post intervention (12-weeks).

  2. Physical Activity Behavior - Self-reported

    Self-reported physical activity is assessed by the Godin Leisure Time Exercise Questionnaire. Higher scores indicate higher levels of physical activity. Participants reporting moderate-to-strenuous Leisure Score Index ≥ 24 are classified as active; those reporting moderate-to-strenuous Leisure Score Index ≤ 23 are classified as insufficiently active.

    Time frame: Baseline, mid-program (6-weeks), and post intervention (12-weeks).

  3. Resting heart rate

    Resting heart rate

    Time frame: Pre to post intervention (12-week change)

  4. Resting Blood Pressure

    Resting systolic and diastolic blood pressure

    Time frame: Pre to post intervention (12-week change)

  5. Aerobic fitness

    The six-minute walk test is used to assess aerobic capacity.

    Time frame: Pre to post intervention (12-week change)

  6. Upper Body Strength

    A hand-held dynamometer is used to assess upper body strength.

    Time frame: Pre to post intervention (12-week change)

  7. Muscular Endurance

    The 30-second sit-to-stand is used to assess lower body muscular endurance.

    Time frame: Pre to post intervention (12-week change)

  8. Body Mass Index

    Height and weight is used to assess body mass index

    Time frame: Pre to post intervention (12-week change)

07

Study locations

2 of 2 sites recruiting
  • Physical Activity and Cancer (PAC) Lab
    Halifax, Nova Scotia B3H 2Y9, Canada
    Recruiting
  • Physical Activity and Cancer (PAC) Lab
    Halifax, Nova Scotia B3H 4R2, Canada
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05884073
Lead sponsor
Melanie Keats
Responsible party
Melanie Keats (Principal Investigator, Nova Scotia Health Authority) — Sponsor-investigator
First posted
Jun 1, 2023
Start date
Jan 2, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jun 1, 2026

Study contacts

Melanie Keats, PhD
Contact
melanie.keats@dal.ca
902-494-7173

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion